참고문헌
- Detels R, Breslow L. Current scope and concerns in public health. In: Oxford textbook of public health. 4th ed. Oxford University Press; 2002
- Glagov S, Weisenberg E, Zarins CK, Stankynavicius R, Kloettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. New England J Med 1987; 316: 1371-1375 https://doi.org/10.1056/NEJM198705283162204
- National Heart, Lung, and Blood Institute. Morbidity and mortality: 1998 chartbook on cardiovascular, lung, and blood disease. National Institute of Health; 1998
- 사망원인 통계연보. 통계청; 2001
- Gil R, Di Mario C, Prati F, von Birgelen C, Ruygrok P, Roelandt JR, Serruys PW. Influence of plaque composition on mechanisms of percutaneous transluminal coronary balloon angioplasty assessedby ultrasound imaging. AHJ 1996; 131: 591-597 https://doi.org/10.1016/S0002-8703(96)90541-4
- Di Sciascio G, Patti G, Nasso G, Manzoli A, D' Ambrosio A, Abbate A. Early and long-term results of stenting of diffuse coronary artery disease. Am J Cardiol 2000;86(11): 1166-1170 https://doi.org/10.1016/S0002-9149(00)01197-8
- lijima R, Nakamura M, Kitagawa Y. Comparison of the efficacy of cutting balloon and balloon angioplasty for highrisk in-stent restenosis. Am J Cardiol 2000; 86(8A): 12 li
- Schofer J, Schluter M, Rau T, Hammer F, Haag N, Detlef G. Mathey DG. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study. JACC 2000; 35(6): 1554-1559
-
Zidar J, Fry E, Lambert C. The VENUS trial: a multi-centre registry of the Cordis
$Bx^{TM}$ -stent platform. Am J Cardiol 2000; 86(8A): 17i - Betriu A, Masotti M, Serra A, Alonso J, Fernandez-Aviles F, Gimeno F, Colman T, Zueco J, Delean JL, Garda E, Jose Calabuig J. Randomised comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions. JACC 1999; 34: 1498-1506 https://doi.org/10.1016/S0735-1097(99)00366-6
- Chaitman BR, Rosen AD, Williams DO, Bourassa MG, Aguirre FV, Pitt B, Rautaharju PM, Rogers WJ, Sharaf B, Attubato M, Hardison RM, Srivatsa S, Kouchoukos NT, Stocke K, Sopko G, DetreK, FryeR. Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trial. Circulation 1997; 96: 2162-2170 https://doi.org/10.1161/01.CIR.96.7.2162
- Hospital Episode Statistics. 1999/00 Key Facts and Figures. Department of Health and Human Service; 2001
- 한국심장재단 . 2001년 전국 심장혈관질환 수술현황 http://www.heart.or.kr
- Altman JD, Bayes-Genis A, Schwartz RS. Pathophysiology of restenosis in Restenosis: a Guideto Therapy. Ed. FaxonDP, Martin Dunitz Ltd,London; 2001
- Suzuki T, Kopia GA, Hayashi S, Bailey LR, Llanos G, Wilensky R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung AC, Tio F, Tsao PS, Falotico R, Carter AJ. Stent-based delivery of sirolimus reduces neointirnal formation in a porcine coronary model. Circulation 2001; 104: 1188-1193 https://doi.org/10.1161/hc3601.093987
- Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J. Clin. Invest. 1996;98(10): 2277-2283
- Gregory CR, Huang X, Pratt RE. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995; 59(5): 655-661 https://doi.org/10.1097/00007890-199503150-00002
- Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smoothmuscle cells. Circ. Res. 1995; 76: 412-417
- Serruys PW, Morice MC, Sousa JE. The RAVEL study: a randomized study with the sirolimus coated Bx velocity balloonexpandable stentin the treatment of patients withde novo native coronary arterylesions. Eur Heart J 2001; 22(suppl): 2624
- Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IMF, Seixas AC, Staico R, Mattos LA, Sousa AGMR, Falotico R, Jaeger J, Popma JJ, Serruys PW. Lack of neointimal proliferation after implantation of sirolimus coated stents in human coronary arteries, Circulation 2001; 103: 192-195
- Sousa JE, Costa MA, Abizaid A. Mid(4month) and long-terrn(1-year) QCA and three dimensional IVUS follow-up after implantation of sirolimus-coated stent in human coronary arteries. JACC 2001; 37(2): 29-32 https://doi.org/10.1016/S0735-1097(01)80001-2
- Carter AJ, Bailey LR, Llanos G. Stent basedsirolimus delivery reduces neointirnal proliferation in a porcine coronary model of restenosis. JACC 2000; 35: 1041-1085
- Klugherz BD, Llanos G, Kopia GA . Intramural kinetics of sirolimus elutedfrom an intracoronary stent. Circulation 2000; 102(18): 35-44 https://doi.org/10.1161/01.CIR.102.1.35
-
Lamotte M, Annemans L. A decision analytic model to evaluate the health economic value of the sirolimus-eluting stent(
$CYPHER^{TM}$ ) in acute coronary artery disease. HEDM; 2002 - Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, Giessen WVD,Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA, the Benestent Study Group. Randomized comparison of implantation of heparin coated stents with balloon angioplasty in selected patients with coronary artery clisease (Benestent II).Lancet 1998;352(9192): 673-681
-
Morice MC. A Randomized double-blind study with the Sirolimus-eluting Bx
$Velocity^{TM}$ balloon expandable stent in the treatment of patients with de novo native coronary artery Lesions. ESC congress Stockholm; 2001 - Kiemeneij F, Serruys PW, Macaya C, Rutsch W, Heyndrickx G, Albertsson FajadetJ, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, Disco CMC, Morel MA, Benestent I Study Group. Continued benefit of coronary stenting versus balloon angioplasty: five year follow-up of Benestent-I trial. J Am Call Cardiol 2001; 37(6): 1598-1603 https://doi.org/10.1016/S0735-1097(01)01207-4
- Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, RyanT, SmithH, Whitlow P, Wiens R, Mark DB, Rosen AD, Detre K, Frye RL, The BypassAngioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation(BARI) Investigators. N Eng J Med 1997; 336(2): 92-99
- 건강보험심사통계연보. 건강보험심사평가원; 2000
- Petitti DB. Meta-analysis, decision analysis and cost-effectiveness analysis. New York, Oxford, Oxford University Press; 1994
- Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi DC, Jang YS, Lam RL, Weissman NJ, Mintz GS. A Placitaxel-eluting stenting for the prevention of coronary restenosis. N Engl J Med2003; 348: 1537-1545 https://doi.org/10.1056/NEJMoa021007